Sfoglia per Autore
Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma
2007-01-01 BALAKRISHNAN A; BLEEKER FE; LAMBA S; RODOLFO M; DANIOTTI M; SCARPA A; VAN TILBORG AA; LEENSTRA S; ZANON C; BARDELLI A
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses
2008-01-01 Di Nicolantonio F ; Arena S; Gallicchio M; Zecchin D; Martini M; Flonta SE; Stella GM; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A
AKT1 (E17K) in human solid tumours
2008-01-01 Bleeker FE; Felicioni L; Buttitta F; Lamba S; Cardone L; Rodolfo M; Scarpa A; Leenstra S; Frattini M; Barbareschi M; Del Grammastro M; Sciarrotta MG; Zanon C; Marchetti A; Bardelli A
Mutational profiling of Cancer Candidate genes in Glioblastoma, Melanoma and Pancreatic Carcinoma reveals a snapshot of their genomic landscapes
2009-01-01 Bleeker FE*; Lamba S*; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A; (* Shared first authorship)
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES
2009-01-01 Gallicchio M; Di Nicolantonio F; Arena S.; Zecchin D; Martini M; Flonta S; Stella G; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A.
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors
2009-01-01 Bleeker FE; Lamba S; Leenstra S; Troost D; Hulsebos T; Vandertop WP; Frattini M; Molinari F; Knowles M; Cerrato A; Rodolfo M; Scarpa A; Felicioni L; Buttitta F; Malatesta S; Marchetti A; Bardelli A
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer
2009-01-01 Sartore-Bianchi A*; Di Nicolantonio F*; Nichelatti M; Molinari F; De Dosso S; Saletti P; Martini M; Cipani T; Marrapese G; Mazzucchelli L; Lamba S; Veronese S; Frattini M; Bardelli A;^ Siena S^ (*shared first authorship; ^shared last authorship)
Mutational profile of GNAQQ209 in human tumors
2009-01-01 Lamba S; Felicioni L; Buttitta F; Bleeker FE; Malatesta S; Corbo V; Scarpa A; Rodolfo M; Knowles M; Frattini M; Marchetti A; Bardelli A
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer
2009-01-01 Balakrishnan A; Penachioni JY; Lamba S; Bleeker FE; Zanon C; Rodolfo M; Vallacchi V; Scarpa A; Felicioni L; Buck M; Marchetti A; Comoglio PM; Bardelli A; Tamagnone L.
Absence of AKT1 mutations in glioblastoma
2009-01-01 Bleeker FE; Lamba S; Zanon C; van Tilborg AA; Leenstra S; Troost D; Hulsebos T; Vandertop WP; Bardelli A
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer
2010-01-01 Sartore-Bianchi A; Bencardino K; Di Nicolantonio F; Pozzi F; Funaioli C; Gambi V; Arena S; Martini M; Lamba S; Cassingena A; Schiavo R; Bardelli A; Siena S
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.
2010-01-01 De Roock, W;* Jonker, Dj;* Di Nicolantonio, F; * Sartore-Bianchi, A; Tu, D; Siena, S; Lamba, S; Arena, S; Frattini, M; Piessevaux, H; Van Cutsem, E; O'Callaghan, Cj; Khambata-Ford, S; Zalcberg, Jr; Simes, J; Karapetis, Cs; Bardelli, A; Tejpar, S. (*co-first authorship)
The prognostic IDH1 ( R132 ) mutation is associated with reduced NADP (+)-dependent IDH activity in glioblastoma
2010-01-01 Bleeker FE; Atai NA; Lamba S; Jonker A; Rijkeboer D; Bosch KS; Tigchelaar W; Troost D; Vandertop WP; Bardelli A; Van Noorden CJ
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type
2010-01-01 Barbi S; Cataldo I; De Manzoni G; Bersani S; Lamba S; Mattuzzi S; Bardelli A; Scarpa A
Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling
2011-01-01 Goodall J; Hunt J; Chen Z; Di Nicolantonio F; Gallicchio M; Lamba S; Bardelli A; Mahoney C; Astley H; Torrance C; Grimshaw K
Ras Mutations in Cancer
2013-01-01 Ludovic Barault; Simona Lamba; Federica Di Nicolantonio
Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis
2013-01-01 M. Martini; M. Russo; S. Lamba; E. Vitiello; E. H. Crowley; F. Sassi; D. Romanelli; M. Frattini; A. Marchetti; A. Bardelli
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy.
2013-01-01 Valtorta E; Misale S; Sartore-Bianchi A; Nagtegaal ID; Paraf F; Lauricella C; Dimartino V; Hobor S; Jacobs B; Ercolani C; Lamba S; Scala E; Veronese S ;Laurent-Puig P; Siena S; Tejpar S; Mottolese M; Punt CJ; Gambacorta M; Bardelli A; Di Nicolantonio F
Targeted Knock-in of the Polymorphism rs61764370 Does Not Affect KRAS Expression but Reduces let-7 Levels
2014-01-01 Emily Hannah Crowley;Sabrina Arena;Simona Lamba;Federica Di Nicolantonio;Alberto Bardelli
Mutational profiling of kinases in glioblastoma.
2014-01-01 Bleeker FE;Lamba S;Zanon C;Molenaar RJ;Hulsebos TJ;Troost D;van Tilborg AA;Vandertop WP;Leenstra S;van Noorden CJ;Bardelli A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma | 2007 | BALAKRISHNAN A; BLEEKER FE; LAMBA S; RODOLFO M; DANIOTTI M; SCARPA A; VAN TILBORG AA; LEENSTRA S; ZANON C; BARDELLI A | |
| Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses | 2008 | Di Nicolantonio F ; Arena S; Gallicchio M; Zecchin D; Martini M; Flonta SE; Stella GM; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A | |
| AKT1 (E17K) in human solid tumours | 2008 | Bleeker FE; Felicioni L; Buttitta F; Lamba S; Cardone L; Rodolfo M; Scarpa A; Leenstra S; Frattini M; Barbareschi M; Del Grammastro M; Sciarrotta MG; Zanon C; Marchetti A; Bardelli A | |
| Mutational profiling of Cancer Candidate genes in Glioblastoma, Melanoma and Pancreatic Carcinoma reveals a snapshot of their genomic landscapes | 2009 | Bleeker FE*; Lamba S*; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A; (* Shared first authorship) | |
| EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES | 2009 | Gallicchio M; Di Nicolantonio F; Arena S.; Zecchin D; Martini M; Flonta S; Stella G; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A. | |
| IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors | 2009 | Bleeker FE; Lamba S; Leenstra S; Troost D; Hulsebos T; Vandertop WP; Frattini M; Molinari F; Knowles M; Cerrato A; Rodolfo M; Scarpa A; Felicioni L; Buttitta F; Malatesta S; Marchetti A; Bardelli A | |
| Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer | 2009 | Sartore-Bianchi A*; Di Nicolantonio F*; Nichelatti M; Molinari F; De Dosso S; Saletti P; Martini M; Cipani T; Marrapese G; Mazzucchelli L; Lamba S; Veronese S; Frattini M; Bardelli A;^ Siena S^ (*shared first authorship; ^shared last authorship) | |
| Mutational profile of GNAQQ209 in human tumors | 2009 | Lamba S; Felicioni L; Buttitta F; Bleeker FE; Malatesta S; Corbo V; Scarpa A; Rodolfo M; Knowles M; Frattini M; Marchetti A; Bardelli A | |
| Molecular profiling of the "plexinome" in melanoma and pancreatic cancer | 2009 | Balakrishnan A; Penachioni JY; Lamba S; Bleeker FE; Zanon C; Rodolfo M; Vallacchi V; Scarpa A; Felicioni L; Buck M; Marchetti A; Comoglio PM; Bardelli A; Tamagnone L. | |
| Absence of AKT1 mutations in glioblastoma | 2009 | Bleeker FE; Lamba S; Zanon C; van Tilborg AA; Leenstra S; Troost D; Hulsebos T; Vandertop WP; Bardelli A | |
| Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer | 2010 | Sartore-Bianchi A; Bencardino K; Di Nicolantonio F; Pozzi F; Funaioli C; Gambi V; Arena S; Martini M; Lamba S; Cassingena A; Schiavo R; Bardelli A; Siena S | |
| Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. | 2010 | De Roock, W;* Jonker, Dj;* Di Nicolantonio, F; * Sartore-Bianchi, A; Tu, D; Siena, S; Lamba, S; Arena, S; Frattini, M; Piessevaux, H; Van Cutsem, E; O'Callaghan, Cj; Khambata-Ford, S; Zalcberg, Jr; Simes, J; Karapetis, Cs; Bardelli, A; Tejpar, S. (*co-first authorship) | |
| The prognostic IDH1 ( R132 ) mutation is associated with reduced NADP (+)-dependent IDH activity in glioblastoma | 2010 | Bleeker FE; Atai NA; Lamba S; Jonker A; Rijkeboer D; Bosch KS; Tigchelaar W; Troost D; Vandertop WP; Bardelli A; Van Noorden CJ | |
| The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type | 2010 | Barbi S; Cataldo I; De Manzoni G; Bersani S; Lamba S; Mattuzzi S; Bardelli A; Scarpa A | |
| Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling | 2011 | Goodall J; Hunt J; Chen Z; Di Nicolantonio F; Gallicchio M; Lamba S; Bardelli A; Mahoney C; Astley H; Torrance C; Grimshaw K | |
| Ras Mutations in Cancer | 2013 | Ludovic Barault; Simona Lamba; Federica Di Nicolantonio | |
| Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis | 2013 | M. Martini; M. Russo; S. Lamba; E. Vitiello; E. H. Crowley; F. Sassi; D. Romanelli; M. Frattini; A. Marchetti; A. Bardelli | |
| KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. | 2013 | Valtorta E; Misale S; Sartore-Bianchi A; Nagtegaal ID; Paraf F; Lauricella C; Dimartino V; Hobor S; Jacobs B; Ercolani C; Lamba S; Scala E; Veronese S ;Laurent-Puig P; Siena S; Tejpar S; Mottolese M; Punt CJ; Gambacorta M; Bardelli A; Di Nicolantonio F | |
| Targeted Knock-in of the Polymorphism rs61764370 Does Not Affect KRAS Expression but Reduces let-7 Levels | 2014 | Emily Hannah Crowley;Sabrina Arena;Simona Lamba;Federica Di Nicolantonio;Alberto Bardelli | |
| Mutational profiling of kinases in glioblastoma. | 2014 | Bleeker FE;Lamba S;Zanon C;Molenaar RJ;Hulsebos TJ;Troost D;van Tilborg AA;Vandertop WP;Leenstra S;van Noorden CJ;Bardelli A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile